Nuzenio

Corbus Pharmaceuticals Holdings

Corbus Pharmaceuticals Holdings news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 11 publisher sources 100/100 entity strength

Latest news

Corbus Pharmaceuticals Holdings Inc Actuals & Estimates (NASDAQ:CRBP) - TradingViewTradingView · Sat, 08 Aug 2026 21:06:22 GMT Corbus Pharmaceuticals Holdings Inc (CRBP) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKeyTradingKey · Sat, 08 Aug 2026 03:15:16 GMT Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors on strong trading day - MarketWatchMarketWatch · Fri, 07 Aug 2026 21:19:00 GMT CRBP (NASDAQ: CRBP) insider plans 12,000-share sale via Stifel - Stock TitanStock Titan · Fri, 07 Aug 2026 20:24:21 GMT CRBP (CRBP) holder files to sell 17,000 Nasdaq-traded shares - Stock TitanStock Titan · Fri, 07 Aug 2026 20:05:13 GMT Oppenheimer Adjusts PT on Corbus Pharmaceuticals to $48 From $52, Maintains Outperform Rating - marketscreener.commarketscreener.com · Fri, 07 Aug 2026 13:44:11 GMT Corbus Pharmaceuticals (NASDAQ: CRBP) ramps R&D to $51M as cash backs key trials - Stock TitanStock Titan · Thu, 06 Aug 2026 20:36:18 GMT Corbus Pharmaceuticals Holdings, Inc. reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Thu, 06 Aug 2026 14:23:44 GMT

Timeline

Sat, 08 Aug 2026 21:06:22 GMTCorbus Pharmaceuticals Holdings Inc Actuals & Estimates (NASDAQ:CRBP) - TradingView

Sat, 08 Aug 2026 03:15:16 GMTCorbus Pharmaceuticals Holdings Inc (CRBP) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Fri, 07 Aug 2026 21:19:00 GMTCorbus Pharmaceuticals Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch

Fri, 07 Aug 2026 20:24:21 GMTCRBP (NASDAQ: CRBP) insider plans 12,000-share sale via Stifel - Stock Titan

Fri, 07 Aug 2026 20:05:13 GMTCRBP (CRBP) holder files to sell 17,000 Nasdaq-traded shares - Stock Titan

Fri, 07 Aug 2026 13:44:11 GMTOppenheimer Adjusts PT on Corbus Pharmaceuticals to $48 From $52, Maintains Outperform Rating - marketscreener.com

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

CRBP27 live mentions Inc12 live mentions NASDAQ8 live mentions Corbus Pharmaceuticals7 live mentions Holdings Inc4 live mentions TradingKey TradingKey4 live mentions Stock Titan Stock4 live mentions Titan4 live mentions Corbus Pharmaceuticals Announces4 live mentions CRB4 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Corbus Pharmaceuticals Holdings.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

11 distinct publisher/source names are currently connected to this entity page.